Literature DB >> 28922782

Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few.

Paula R Pohlmann1, Claudine Isaacs1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28922782      PMCID： PMC6279308          DOI： 10.1093/jnci/djx142

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  20 in total

Review 1.  Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Hadar Goldvaser; Tristan A Barnes; Boštjan Šeruga; David W Cescon; Alberto Ocaña; Domen Ribnikar; Eitan Amir
Journal:  J Natl Cancer Inst       Date:  2018-01-01       Impact factor: 13.506

Review 2.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Lyndsay N Harris; Nofisat Ismaila; Lisa M McShane; Fabrice Andre; Deborah E Collyar; Ana M Gonzalez-Angulo; Elizabeth H Hammond; Nicole M Kuderer; Minetta C Liu; Robert G Mennel; Catherine Van Poznak; Robert C Bast; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

3.  Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

Authors:  Jacqueline A Shaw; Karen Page; Kevin Blighe; Natasha Hava; David Guttery; Becky Ward; James Brown; Chetana Ruangpratheep; Justin Stebbing; Rachel Payne; Carlo Palmieri; Suzy Cleator; Rosemary A Walker; R Charles Coombes
Journal:  Genome Res       Date:  2011-10-11       Impact factor: 9.043

4.  The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Authors:  Martin Filipits; Torsten O Nielsen; Margaretha Rudas; Richard Greil; Herbert Stöger; Raimund Jakesz; Zsuzsanna Bago-Horvath; Otto Dietze; Peter Regitnig; Christine Gruber-Rossipal; Elisabeth Müller-Holzner; Christian F Singer; Brigitte Mlineritsch; Peter Dubsky; Thomas Bauernhofer; Michael Hubalek; Michael Knauer; Harald Trapl; Christian Fesl; Carl Schaper; Sean Ferree; Shuzhen Liu; J Wayne Cowens; Michael Gnant
Journal:  Clin Cancer Res       Date:  2014-02-11       Impact factor: 12.531

5.  Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Authors:  Raimund Jakesz; Richard Greil; Michael Gnant; Marianne Schmid; Werner Kwasny; Ernst Kubista; Brigitte Mlineritsch; Christoph Tausch; Michael Stierer; Friedrich Hofbauer; Karl Renner; Christian Dadak; Ernst Rücklinger; Hellmut Samonigg
Journal:  J Natl Cancer Inst       Date:  2007-12-11       Impact factor: 13.506

6.  Quality of life of women with recurrent breast cancer and their family members.

Authors:  Laurel L Northouse; Darlene Mood; Trace Kershaw; Ann Schafenacker; Suzanne Mellon; Julie Walker; Elizabeth Galvin; Veronica Decker
Journal:  J Clin Oncol       Date:  2002-10-01       Impact factor: 44.544

7.  Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

Authors:  Paul E Goss; James N Ingle; Kathleen I Pritchard; Nicholas J Robert; Hyman Muss; Julie Gralow; Karen Gelmon; Tim Whelan; Kathrin Strasser-Weippl; Sheldon Rubin; Keren Sturtz; Antonio C Wolff; Eric Winer; Clifford Hudis; Alison Stopeck; J Thaddeus Beck; Judith S Kaur; Kate Whelan; Dongsheng Tu; Wendy R Parulekar
Journal:  N Engl J Med       Date:  2016-06-05       Impact factor: 91.245

8.  Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study.

Authors:  B Yeo; L Zabaglo; M Hills; A Dodson; I Smith; M Dowsett
Journal:  Br J Cancer       Date:  2015-07-16       Impact factor: 7.640

9.  Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

Authors:  Dennis C Sgroi; Ivana Sestak; Jack Cuzick; Yi Zhang; Catherine A Schnabel; Brock Schroeder; Mark G Erlander; Anita Dunbier; Kally Sidhu; Elena Lopez-Knowles; Paul E Goss; Mitch Dowsett
Journal:  Lancet Oncol       Date:  2013-09-12       Impact factor: 41.316

10.  Clonal evolution in breast cancer revealed by single nucleus genome sequencing.

Authors:  Yong Wang; Jill Waters; Marco L Leung; Anna Unruh; Whijae Roh; Xiuqing Shi; Ken Chen; Paul Scheet; Selina Vattathil; Han Liang; Asha Multani; Hong Zhang; Rui Zhao; Franziska Michor; Funda Meric-Bernstam; Nicholas E Navin
Journal:  Nature       Date:  2014-07-30       Impact factor: 49.962
View more
  1 in total

1.  Extended duration of adjuvant aromatase inhibitor in breast cancer: a meta-analysis of randomized controlled trials.

Authors:  Zackariah Clement; James Kollias; Janne Bingham; Robert Whitfield; Melissa Bochner
Journal:  Gland Surg       Date:  2018-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.